Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

Helen Gharwan, MD, DSc, Kieron Dunleavy, MD, Margaret Shovlin, RN, Antonio T Fojo, MD, PhD, Thomas A. Fleisher, MD, Wyndham H Wilson, MD, PhD, Cliona Grant, MD

Blood (2013) 122 (21): 1779.

https://doi.org/10.1182/blood.V122.21.1779.1779

Published: 2013

Journal Articles

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

Katie Perkins, NP, Joie Davis, NP, Susan Price, RN, Julie Niemela, PhD, Andreas R. Huber, MD, Donna A. Wall, MD, Stefania Pittaluga, MD, PhD, Thomas A. Fleisher, MD, V. Koneti Rao, MD

Blood (2012) 120 (21): 2149.

https://doi.org/10.1182/blood.V120.21.2149.2149

Published: 2012

Journal Articles

The BH3 Mimetic, Small Molecule, ABT-737, Was Effective As Lympholytic Therapy in the MRL/lpr −/− Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

Kennichi C. Dowdell, PhD, Lu Lianghao, MD, PhD, V. Koneti Rao, Thomas A. Fleisher, MD, Joao Bosco Oliveira, MD, PhD

Blood (2011) 118 (21): 695.

https://doi.org/10.1182/blood.V118.21.695.695

Published: 2011

Journal Articles

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Kieron Dunleavy, MD, Benjamin L.W. Reiter, Cliona M. Grant, MD, Margaret Shovlin, RN, George W. Wright, Thomas A. Fleisher, MD, Wyndham H. Wilson, MD, PhD

Blood (2010) 116 (21): 2881.

https://doi.org/10.1182/blood.V116.21.2881.2881

Published: 2010

Journal Articles

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Kamal Sharma, DO, John E. Janik, MD, Deirdre O’Mahony, MD, Donn Stewart, MD, Stefania Pittaluga, MD, Maryalice Stetler-Stevenson, MD, PhD, Elaine S. Jaffe, MD, Mark Raffeld, MD, Thomas A. Fleisher, MD, Cathryn C. Lee, NP, Nicole Urquhart, MD, Seth Steinberg, PhD, Thomas A. Waldmann, MD, John C. Morris, MD

Blood (2008) 112 (11): 2010.

https://doi.org/10.1182/blood.V112.11.2010.2010

Published: 2008

Journal Articles

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Raffick AR Bowen, MLT, PhD, DClChem, FCACB, DABCC, Janet K Dale, RN, MPH, Margaret Brown, BSc, Steven K Drake, PhD, Tarsilla Moura, Kennichi Dowdell, PhD, Alan T Remaley, MD, PhD, Thomas A Fleisher, MD, Glen L Hortin, MD, PhD, Ebba Nexo, MD, Stephen E Straus, MD, V. Koneti Rao, MD, FRCPA

Blood (2008) 112 (11): 4898.

https://doi.org/10.1182/blood.V112.11.4898.4898

Published: 2008

Journal Articles

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

V. Koneti Rao, MD, Kennichi C. Dowdell, PhD, Faith Dugan, RN, Janet K. Dale, RN, MPH, Lesley Pesnicak, Lilia Bi, PhD, Scott Penzak, Pharm D, Nilo A. Avila, MD, Thomas A. Fleisher, MD, Jennifer M. Puck, MD, Stephen E. Straus, MD

Blood (2005) 106 (11): 2396.

https://doi.org/10.1182/blood.V106.11.2396.2396

Published: 2005

NARROW

Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

The BH3 Mimetic, Small Molecule, ABT-737, Was Effective As Lympholytic Therapy in the MRL/lpr −/− Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Email alerts

ASH Publications

American Society of Hematology

Study On The Fertility Status Of Females With Primary Mediastinal B-Cell Lymphoma Following Treatment With Dose-Adjusted EPOCH-Rituximab

Expanding Spectrum of Malignancies in ALPS: A Cancer Predisposing Syndrome?.

The BH3 Mimetic, Small Molecule, ABT-737, Was Effective As Lympholytic Therapy in the MRL/lpr −/− Mouse Model of Autoimmune Lymphoproliferative Syndrome (ALPS)

Rituximab Is Associated with Prolonged Immunoglobulin Deficiency In Newly Diagnosed Patients with Aggressive B-Cell Lymphoma Receiving Immunochemotherapy

Alemtuzumab (Campath 1-H) in Patients with HTLV-1 Associated Adult T-Cell Leukemia/Lymphoma.

Significantly Elevated Vitamin B 12 Levels in Autoimmune Lymphoproliferative Syndrome (ALPS), a Rare Lymphoproliferative Disorder with Apoptosis Defect

Pyrimethamine Does Not Diminish Lymphoproliferation in MRL/lpr−/− Mice and Patients with Autoimmune Lymphoproliferative Syndrome (ALPS).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only